相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Affordable Care Act Moving Forward in the Coming Years
Lawrence O. Gostin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
The Future of the ACA and Health Care Policy in the United States
Gail R. Wilensky
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
What will Donald Trump's presidency mean for health? A scorecard
Martin McKee et al.
LANCET (2017)
Essential medicines for universal health coverage
Veronika J. Wirtz et al.
LANCET (2017)
Care for the Vulnerable vs. Cash for the Powerful - Trump's Pick for HHS
Sherry A. Glied et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Repealing the ACA without a Replacement - The Risks to American Health Care
Barack H. Obama
NEW ENGLAND JOURNAL OF MEDICINE (2017)
FDA Regulation of Prescription Drugs
Audrey L. Gassman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Republican plan to repeal Obamacare draws fire from left and right
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2017)
Republican plan to repeal Obamacare draws fire from left and right
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2017)
A comparison of generic drug prices in seven European countries: a methodological analysis
Olivier J. Wouters et al.
BMC HEALTH SERVICES RESEARCH (2017)
Policy interventions related to medicines: Survey of measures taken in European countries during 2010-2015
Sabine Vogler et al.
HEALTH POLICY (2016)
Role of the FDA in Affordability of Off-Patent Pharmaceuticals
Jeremy A. Greene et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
United States Health Care Reform Progress to Date and Next Steps
Barack Obama
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform
Aaron S. Kesselheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey
Aaron S. Kesselheim et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2016)
Prescription Drug Pricing Is Not Just an Election Issue
Gail R. Wilensky
MILBANK QUARTERLY (2016)
Competition authority will investigate price hikes of generic drugs
Nigel Hawkes
BMJ-BRITISH MEDICAL JOURNAL (2016)
States sue generic drug makers for alleged price fixing
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2016)
Competition authority will investigate price hikes of generic drugs
Nigel Hawkes
BMJ-BRITISH MEDICAL JOURNAL (2016)
States sue generic drug makers for alleged price fixing
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2016)
Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015
Miranda E. Rosenberg et al.
JAMA DERMATOLOGY (2016)
Therapeutic Substitution-Should It Be Systematic or Automatic?
Joseph S. Ross
JAMA INTERNAL MEDICINE (2016)
Prevalence and Predictors of Generic Drug Skepticism Among Physicians: Results of a National Survey
Aaron S. Kesselheim et al.
JAMA INTERNAL MEDICINE (2016)
How Patent Troll Legislation Can Increase Timely Access to Generic Drugs
Carolyn L. Treasure et al.
JAMA INTERNAL MEDICINE (2016)
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts
James S. Yeh et al.
JAMA INTERNAL MEDICINE (2016)
Estimation of Potential Savings Through Therapeutic Substitution
Michael E. Johansen et al.
JAMA INTERNAL MEDICINE (2016)
Cost-Sharing Rates Increase During Deep Recession: Preliminary Data From Greece
Athanasios Gouvalas et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2016)
What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs
Suzanne S. Dunne et al.
BMC MEDICINE (2015)
Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform
Olivier J. Wouters et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2015)
Patients' perceptions of generic drugs in Greece
Leonora N. Skaltsas et al.
HEALTH POLICY (2015)
Generic drug market: growing and merging
The Lancet Oncology
LANCET ONCOLOGY (2015)
Why Are Cancer Drugs So Expensive in the United States, and What Are the Solutions?
Hagop Kantarjian et al.
MAYO CLINIC PROCEEDINGS (2015)
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Daniel M. Hartung et al.
NEUROLOGY (2015)
Why Is There No Generic Insulin? Historical Origins of a Modern Problem
Jeremy A. Greene et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review
Sarah Colgan et al.
BMJ OPEN (2015)
US Senate committee launches investigation into drug pricing
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2015)
Senate committee inquiry into drug price hikes will continue despite arrest of hedge fund manager Shkreli
Owen Dyer
BMJ-BRITISH MEDICAL JOURNAL (2015)
DATA BRIEFING The rise and rise of generic prescribing
John Appleby
BMJ-BRITISH MEDICAL JOURNAL (2015)
Rosuvastatin: winner in the statin wars, patients' health notwithstanding
Sidney Wolfe
BMJ-BRITISH MEDICAL JOURNAL (2015)
Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
Ameet Sarpatwari et al.
PLOS MEDICINE (2015)
US Senate committee launches investigation into drug pricing
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2015)
Senate committee inquiry into drug price hikes will continue despite arrest of hedge fund manager Shkreli
Owen Dyer
BMJ-BRITISH MEDICAL JOURNAL (2015)
DATA BRIEFING The rise and rise of generic prescribing
John Appleby
BMJ-BRITISH MEDICAL JOURNAL (2015)
Rosuvastatin: winner in the statin wars, patients' health notwithstanding
Sidney Wolfe
BMJ-BRITISH MEDICAL JOURNAL (2015)
Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014
Jing Luo et al.
JAMA INTERNAL MEDICINE (2015)
Public outcry over US generic drug price hikes
Bryant Furlow
Lancet Respiratory Medicine (2015)
Regulatory Solutions to the Problem of High Generic Drug Costs
Jing Luo et al.
Open Forum Infectious Diseases (2015)
A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?
Else-Lydia Toverud et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2015)
Evolution of cost structures in rheumatoid arthritis over the past decade
Doerte Huscher et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Pricing in the Market for Anticancer Drugs
David H. Howard et al.
JOURNAL OF ECONOMIC PERSPECTIVES (2015)
Burden of Changes in Pill Appearance for Patients Receiving Generic Cardiovascular Medications After Myocardial Infarction Cohort and Nested Case-Control Studies
Aaron S. Kesselheim et al.
ANNALS OF INTERNAL MEDICINE (2014)
Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes A Cohort Study
Joshua J. Gagne et al.
ANNALS OF INTERNAL MEDICINE (2014)
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
Christine Leopold et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2014)
Medication Affordability Gains Following Medicare Part D Are Eroding Among Elderly With Multiple Chronic Conditions
Huseyin Naci et al.
HEALTH AFFAIRS (2014)
Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States
Panos Kanavos
HEALTH POLICY (2014)
Potential Savings Associated with Drug Substitution in Medicare Part D: The Translating Research into Action for Diabetes (TRIAD) Study
O. Kenrik Duru et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2014)
Price regulation and relative delays in generic drug adoption
Joan Costa-Font et al.
JOURNAL OF HEALTH ECONOMICS (2014)
Trial watch Personalized medicines in late-stage development
Christopher-Paul Milne et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Using a Drug-Safety Tool to Prevent Competition
Ameet Sarpatwari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Cost Generic Drugs - Implications for Patients and Policymakers
Jonathan D. Alpern et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Association of Marketing Interactions With Medical Trainees' Knowledge About Evidence-Based Prescribing Results From a National Survey
Kirsten E. Austad et al.
JAMA INTERNAL MEDICINE (2014)
The Changing Role of Government in Financing Health Care: An International Perspective
Mark Stabile et al.
JOURNAL OF ECONOMIC LITERATURE (2014)
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Camille Abboud et al.
BLOOD (2013)
Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs
Panos Kanavos et al.
HEALTH AFFAIRS (2013)
Cancer Drugs in the United States: Justum Pretium-The Just Price
Hagop M. Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The ACA and High-Deductible Insurance - Strategies for Sharpening a Blunt Instrument
J. Frank Wharam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Demand-side policies to encourage the use of generic medicines: an overview
Pieter Dylst et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
Physician Acquiescence to Patient Demands for Brand-Name Drugs: Results of a National Survey of Physicians
Eric G. Campbell et al.
JAMA INTERNAL MEDICINE (2013)
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study
Suzanne Dunne et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
Perceptions and patterns of use of generic drugs among Italian Family Pediatricians: First round results of a web survey
Valentina Fabiano et al.
HEALTH POLICY (2012)
HISTORY OF MEDICINE Reform, Regulation, and Pharmaceuticals - The Kefauver-Harris Amendments at 50
Jeremy A. Greene et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries-an overview
Sabine Vogler
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2012)
Reference pricing systems in Europe: characteristics and consequences
Pieter Dylst et al.
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2012)
The Consequences of Requesting Dispense as Written
William H. Shrank et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Physician Perceptions About Generic Drugs
William H. Shrank et al.
ANNALS OF PHARMACOTHERAPY (2011)
Potential Savings From Greater Use of $4 Generic Drugs
Yuting Zhang et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Determinants of generic drug substitution in Switzerland
Anne Decollogny et al.
BMC HEALTH SERVICES RESEARCH (2011)
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe
Atholl Johnston et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The Use Of Generic Drugs In Prevention Of Chronic Disease Is Far More Cost-Effective Than Thought, And May Save Money
William H. Shrank et al.
HEALTH AFFAIRS (2011)
Tendering for outpatient prescription pharmaceuticals: What can be learned from current practices in Europe?
Pieter Dylst et al.
HEALTH POLICY (2011)
What's in a Name? Generics and the Persistence of the Pharmaceutical Brand in American Medicine
Jeremy A. Greene
JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES (2011)
Why Do the Same Drugs Look Different? Pills, Trade Dress, and Public Health
Jeremy A. Greene et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effects of Reference Pricing in Pharmaceutical Markets A Review
Matteo Maria Galizzi et al.
PHARMACOECONOMICS (2011)
Bioequivalence: The Regulatory Career of a Pharmaceutical Concept
Daniel Carpenter et al.
BULLETIN OF THE HISTORY OF MEDICINE (2011)
Generic and therapeutic substitutions in the UK: are they a good thing?
Martin G. Duerden et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs A Systematic Review and Meta-Analysis
Aaron S. Kesselheim et al.
DRUGS (2010)
State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid
William H. Shrank et al.
HEALTH AFFAIRS (2010)
Is History Relevant to Implementing Health Reform?
Daniel M. Fox et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Incentives for Drug Development - The Curious Case of Colchicine
Aaron S. Kesselheim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Impact of European Pharmaceutical Price Regulation on Generic Price Competition A Review
Jaume Puig-Junoy
PHARMACOECONOMICS (2010)
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Barbara M. Davit et al.
ANNALS OF PHARMACOTHERAPY (2009)
Patients' Perceptions Of Generic Medications
William H. Shrank et al.
HEALTH AFFAIRS (2009)
Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years
Karolina A. Andersson et al.
BMC HEALTH SERVICES RESEARCH (2008)
International prices and availability of pharmaceuticals in 2005
Patricia M. Danzon et al.
HEALTH AFFAIRS (2008)
Key principles for the improved conduct of health technology assessments for resource allocation decisions
Michael F. Drummond et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2008)
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis
Aaron S. Kesselheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Allied Against Reform: Pharmaceutical Industry-Academic Physician Relations in the United States, 1945-1970
Dominique A. Tobbell
BULLETIN OF THE HISTORY OF MEDICINE (2008)
In search of a corrected prescription drug elasticity estimate: A meta-regression approach
Marin C. Gemmill et al.
HEALTH ECONOMICS (2007)
Emerging lessons from the drug effectiveness review project
Peter J. Neumann
HEALTH AFFAIRS (2006)
Perspective - The drug effectiveness review project: An important step forward
Mark Gibson et al.
HEALTH AFFAIRS (2006)
The implications of choice - Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions
WH Shrank et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
High and rising health care costs. Part 2: Technologic innovation
T Bodenheimer
ANNALS OF INTERNAL MEDICINE (2005)
Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000
JS Haas et al.
ANNALS OF INTERNAL MEDICINE (2005)
Economic implications of evidence-based prescribing for hypertension - Can better care cost less?
MA Fischer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit
MA Fischer et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Economic consequences of underuse of generic drugs: Evidence from Medicaid and implications for prescription drug benefit plans
MA Fischer et al.
HEALTH SERVICES RESEARCH (2003)
Does regulation drive out competition in pharmaceutical markets?
PM Danzon et al.
JOURNAL OF LAW & ECONOMICS (2000)
Cross-national price differences for pharmaceuticals: how large, and why?
PM Danzon et al.
JOURNAL OF HEALTH ECONOMICS (2000)
分享论文
